{"id":398189,"date":"2026-04-14T16:18:15","date_gmt":"2026-04-14T16:18:15","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/398189\/"},"modified":"2026-04-14T16:18:15","modified_gmt":"2026-04-14T16:18:15","slug":"study-shows-aker-biomarines-lysoveta-boosts-cognition-by-delivering-omega-3s-to-the-brain","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/398189\/","title":{"rendered":"Study shows Aker BioMarine\u2019s Lysoveta boosts cognition by delivering omega-3s to the brain"},"content":{"rendered":"

New clinical evidence demonstrates that Aker BioMarine\u2019s Lysoveta brain health ingredient supplies eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) through the brain\u2019s protective barriers.\u00a0<\/p>\n

The omega-3 ingredient delivers these compounds in lysophosphatidylcholine, a molecular form of choline that the brain naturally recognizes and actively transports across its barriers via the MFSD2A pathway, which is crucial for importing omega-3s into the brain. Using lysophosphatidylcholine enables more effective targeted delivery.<\/p>\n

\u201cWith a growing burden of brain-related diseases like Alzheimer\u2019s disease and dementia, research into how nutrition can support brain health has never been more important,\u201d says Matts Johansen, CEO of Aker BioMarine.<\/p>\n

Alzheimer\u2019s disease implications<\/p>\n

Researchers found that Lysoveta delivered \u201csignificant enrichment\u201d of the beneficial compounds, including in mice carrying the APOE4 gene, which is a known genetic risk factor for late-onset Alzheimer\u2019s disease.<\/p>\n

\"arrow\"<\/a><\/p>\n

In APOE4 mice, supplementing with the ingredient shifted DHA-related metabolites, indicating that Lysoveta activated relevant pathways in the brain without significantly increasing bulk DHA levels, which was consistent with the distinct lipid metabolism observed in APOE4 carriers.<\/p>\n

\u201cOur results show that Lysoveta can enrich brain-related tissues with EPA and DHA, supporting its potential as a targeted nutritional strategy for brain health. The distinct response observed in APOE4 further underscores the importance of genotype-specific approaches,\u201d explains study author Dr. M\u00e9lanie Plourde from Universit\u00e9 de Sherbrooke, Canada.<\/p>\n

Global challenge<\/p>\n

Aker BioMarine introduced Lysoveta in November 2020 as the world\u2019s first commercially available EPA and DHA ingredient in lysophosphatidylcholine form, resulting from decades of research into krill-derived phospholipids.<\/p>\n

\"RedThe new paper is the third study Lysoveta study that demonstrates its neuroprotective effects and significant enrichment of EPA and DHA in brain tissues.<\/p>\n

This new paper, soon to be published, is the third study with Lysoveta demonstrating neuroprotective effects and significant enrichment of EPA and DHA in brain tissues.<\/p>\n

As populations age and risk factors such as obesity and diabetes continue to rise, Aker BioMarine underscores the urgent need for more research into how nutrition can support brain health. WHO statistics forecast that the number of people living with dementia will triple to 152 million by 2050.<\/p>\n

\u201cEach study brings us closer to understanding what Lysoveta can mean for brain health. The results so far are encouraging. As people live longer and the global population ages, the number of those affected by brain-related diseases will continue to rise, and we need more research to address it,\u201d says Johansen.<\/p>\n

Previously, at SupplySide Global 2025<\/a> in Las Vegas, Nevada, US, Nutrition Insight met with Simon Seward, CEO of human health ingredients at Aker BioMarine, to discuss the latest science behind Lysoveta.<\/p>\n

In other Aker BioMarine developments, the company\u2019s Superba Boost Krill oil was recently greenlit as the first omega-3 ingredient approved for \u201cskin health\u201d claims in Japan<\/a>. The ingredient containing EPA and DHA is backed by clinically proven evidence of supporting skin moisture and barrier function in beauty-from-within supplements.<\/p>\n","protected":false},"excerpt":{"rendered":"New clinical evidence demonstrates that Aker BioMarine\u2019s Lysoveta brain health ingredient supplies eicosapentaenoic acid (EPA) and docosahexaenoic acid…\n","protected":false},"author":2,"featured_media":398190,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[175953,5963,64189,1068,103,61,60,175954,9523],"class_list":{"0":"post-398189","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-aker-biomarine","9":"tag-brain-health","10":"tag-dha","11":"tag-epa","12":"tag-health","13":"tag-ie","14":"tag-ireland","15":"tag-lysoveta","16":"tag-omega-3"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/398189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=398189"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/398189\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/398190"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=398189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=398189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=398189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}